(1Z,4E)-1,5-bis(4-methoxyphenyl)penta-1,4-dien-3-one | 2051-07-2

• 物质功能分类: 化学试剂 - 有机试剂 - 脂肪酮(含烯醇)
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: (1Z,4E)-1,5-bis(4-methoxyphenyl)penta-1,4-dien-3-one
• CAS: 2051-07-2
• 化学式: C₁₉H₁₈O₃
• 分子量: 294.3
• InChiKey: IOZVKDXPBWBUKY-INWPEIIHSA-N

物化性质

• 熔点：
  128-129 °C
• 沸点：
  492℃
• 密度：
  1.128
• 闪点：
  244℃

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  22
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S24/25
• 海关编码：
  2914509090
• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
• 危险性描述：
  H302,H315,H319,H335

文献信息

• NOVEL PYRAZINE AMIDE COMPOUNDS
  申请人：WIEDENMAYER Dieter

  公开号：US20150045326A1

  公开（公告）日：2015-02-12

  The present invention relates to compounds of formula 1 or pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , R 3 , R 5 , R 4 , R 5 , R 6 and X − have the meanings as indicated in the specification, to their use as a medicament, to their use in the treatment of a disease selected from among respiratory diseases or complaints and allergic diseases of the airways, to pharmaceutical composition comprising at least one of said compound or a pharmaceutically acceptable salt thereof, as well as to medicament combinations containing one or more of said compounds or a pharmaceutically acceptable salt thereof.

  本发明涉及式1的化合物或其药用盐，其中R1、R2、R3、R4、R5、R6和X-的含义如规范中所示，以及它们作为药物的用途，用于治疗呼吸道疾病或疾病和过敏性呼吸道疾病中选择的疾病，包括至少一种所述化合物或其药用盐的药物组合的制药组合。
• [EN] NOVEL PYRAZINE AMIDE COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS PYRAZINE-AMIDES
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2015018754A1

  公开（公告）日：2015-02-12

  The present invention relates to compounds of formula 1 or pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, R6 and X- have one of the meanings as indicated in the specification, to their use as a medicament, to their use in the treatment of a disease selected from among respiratory diseases or complaints and allergic diseases of the airways, to pharmaceutical composition comprising at least one of said compound or a pharmaceutically acceptable salt thereof, as well as to medicament combinations containing one or more of said compounds or a pharmaceutically acceptable salt thereof.

  本发明涉及式1的化合物或其药用盐，其中R1、R2、R3、R5、R6和X-具有规范中指示的含义之一，其用作药物，用于治疗呼吸道疾病或疾病和过敏性疾病，包括至少一种所述化合物或其药用盐的药物组合的制药组合。
• GEM-DISUBSTITUTED PYRROLIDINES, PIPERAZINES, AND DIAZEPANES, AND COMPOSITIONS AND METHODS OF MAKING THE SAME
  申请人：California Institute of Technology

  公开号：US20200199114A1

  公开（公告）日：2020-06-25

  Described here are transition metal-catalyzed enantioselective arylation and vinylation reactions of α-substituted lactams, such as γ-lactams. The use of various electrophiles and ligands are described, and result in the construction of α-quaternary centers in good yields (up to 91% yield) and high enantioselectivities (up to 97% ee).

  本文描述了过渡金属催化的α-取代内酰胺（如γ-内酰胺）的选择性芳基化和烯基化反应。描述了使用各种亲电试剂和配体，并导致在良好产率（高达91%收率）和高对映选择性（高达97% ee）下构建α-季铵中心。
• [EN] SPIRO-1,1'-BIINDANE-7,7-BISPHOSPHINE OXIDES AS HIGHLY ACTIVE SUPPORTING LIGANDS FOR PALLADIUM-CATALYZED ASYMMETRIC HECK REACTION<br/>[FR] OXYDES DE SPIRO-1,1'-BIINDANE-7,7-BISPHOSPHINE COMME LIGANDS DE SUPPORT HAUTEMENT ACTIFS POUR UNE RÉACTION DE HECK ASYMÉTRIQUE CATALYSÉE PAR DU PALLADIUM
  申请人：UNIV NANYANG TECH

  公开号：WO2014196930A1

  公开（公告）日：2014-12-11

  The present invention relates to catalyst complexes comprising palladium (Pd) and at least one spiro-1,1 '-biindane-7,7'- bisphosphine oxide ligand as disclosed herein, and their use. The present invention is further directed to the asymmetric Pd-catalyzed covalent carbon-carbon single bond formation from aryl, heteroaryl and alkenyl triflates and halides and olefins utilising the said catalyst complexes.

  本发明涉及包含钯（Pd）和至少一种如本文所述的螺-1,1'-联萘-7,7'-双膦氧配体的催化剂复合物，以及它们的使用。本发明进一步涉及利用所述催化剂复合物从芳基、杂环芳基和烯基三氟甲烷磺酸酯和卤代物以及烯烃中进行不对称Pd催化的共价碳-碳单键形成。
• ENANTIOSELECTIVE SYNTHESIS OF alpha-QUATERNARY MANNICH ADDUCTS BY PALLADIUM-CATALYZED ALLYLIC ALKYLATION
  申请人：California Institute of Technology

  公开号：US20160176773A1

  公开（公告）日：2016-06-23

  This invention provides enantioenriched Mannich adducts with quaternary stereogenic centers and novel methods of preparing the compounds. Methods include the method for the preparation of a compound of formula (I): comprising treating a compound of formula (II): with a transition metal catalyst under alkylation conditions.

  这项发明提供了具有四元立体异构中心的对映富集曼尼希加合物以及制备这些化合物的新方法。该方法包括使用过渡金属催化剂在烷基化条件下处理式（II）化合物的方法，以制备式（I）化合物。